The Trump family’s wealth has soared to $10 billion, driven by crypto, media, and international deals—highlighting the widening divide between presidential power and public prosperity.
Browsing: Economy & Business
Novartis is working with the U.S. government to reduce drug prices, spotlighting the deeper inequities in the global pharmaceutical market.
An ambitious U.S.-Korea partnership aims to build the nation’s first integrated rare earth and magnet supply chain, challenging China’s dominance.
Behind the dollar’s rally, the Fed’s fight for independence and stability matters most.
International sellers are hiking shipping fees as U.S. tariffs spark confusion, surprise charges, and threaten billions in export revenues.
Trump’s executive orders promise lower drug prices, but as global pharma reels and oversight erodes, who really benefits?
Alphabet’s $3 trillion breakthrough exposes the tension between tech progress and unchecked corporate concentration—what does this mean for democracy and innovation?
BlackRock’s $700 million UK data center investment promises new jobs and tech leadership, but critics question whether it delivers real community benefit amid environmental and social concerns.
JPMorgan Chase enabled Jeffrey Epstein for over a decade, ignoring red flags to protect profits and elite connections—even as staff urgently warned of potential sex trafficking.
Despite defiant Kremlin rhetoric, Russia’s “economic resilience” masks deepening inequality, social costs, and an uncertain future. Sanctions alone can’t end the Ukraine war, but they’re changing the fabric of Russian life.